Alvaro Pascual-Leone Selected Research

progressin

1/2022

The Importance of Motivation to Older Adult Physical and Cognitive Exercise Program Development, Initiation, and Adherence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alvaro Pascual-Leone Research Topics

Disease

33	Stroke (Strokes) 01/2022 - 09/2005
17	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2011
15	Seizures (Absence Seizure) 01/2022 - 02/2006
14	Epilepsy (Aura) 05/2021 - 01/2004
13	Pain (Aches) 01/2020 - 05/2006
11	Parkinson Disease (Parkinson's Disease) 01/2020 - 09/2005
9	Schizophrenia (Dementia Praecox) 12/2021 - 07/2002
8	Cognitive Dysfunction 01/2022 - 01/2018
8	Treatment-Resistant Depressive Disorder 01/2022 - 12/2006
7	Aphasia (Dysphasia) 01/2020 - 05/2004
7	Spinal Cord Injuries (Spinal Cord Injury) 04/2015 - 05/2006
6	Dementia (Dementias) 01/2022 - 12/2018
6	Mental Disorders (Mental Disorder) 01/2022 - 03/2003
6	Broca Aphasia (Expressive Aphasia) 01/2014 - 10/2009
5	Delirium 01/2022 - 06/2017
5	Drug Resistant Epilepsy 01/2022 - 01/2005
5	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2007
5	Autism Spectrum Disorder 01/2020 - 01/2010
4	Sleep Apnea Syndromes (Sleep Apnea) 01/2020 - 03/2010
4	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2017 - 10/2008
3	Cerebral Palsy (Spastic Diplegia) 01/2017 - 07/2007
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2016 - 12/2013
3	Asperger Syndrome (Asperger's Syndrome) 01/2014 - 07/2011
3	Dystonia (Limb Dystonia) 09/2012 - 12/2005
3	Chronic Pain 05/2012 - 04/2006
3	Visceral Pain 01/2011 - 01/2007
2	Temporal Lobe Epilepsy 01/2022 - 02/2016
2	COVID-19 12/2021 - 01/2021
2	Partial Epilepsies (Epilepsy, Partial) 05/2021 - 10/2017
2	Ataxia (Dyssynergia) 03/2020 - 10/2013
2	Proteostasis Deficiencies 01/2020 - 01/2019
2	Mood Disorders (Mood Disorder) 12/2019 - 06/2007
2	Paresis (Hemiparesis) 01/2019 - 01/2018
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 05/2017
2	Inflammation (Inflammations) 11/2017 - 01/2011
2	Brain Neoplasms (Brain Tumor) 04/2017 - 01/2012
2	Agnosia (Visual Agnosia) 01/2017 - 01/2017
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017 - 05/2016
2	Nervous System Diseases (Neurological Disorders) 09/2014 - 10/2005
2	Task-Specific Focal Dystonia 01/2014 - 09/2012
2	Atrophy 10/2013 - 04/2008
2	Hemianopsia (Bitemporal Hemianopsia) 07/2012 - 09/2011
2	Neuralgia (Stump Neuralgia) 05/2012 - 09/2010
2	Gambling (Pathological Gambling) 02/2010 - 06/2006
2	Epilepsia Partialis Continua 01/2009 - 07/2008
2	Tinnitus 07/2008 - 04/2006
2	Malformations of Cortical Development 10/2006 - 01/2005
1	Neuroinflammatory Diseases 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Brain Diseases (Brain Disorder) 10/2020
1	Pruritus (Itching) 03/2020
1	Obesity 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Hypercholesterolemia 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Craniocerebral Trauma (Head Injury) 12/2019
1	Hypopituitarism (Sheehan's Syndrome) 12/2019
1	Erectile Dysfunction 12/2019

Drug/Important Bio-Agent (IBA)

29	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2006
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2011
6	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2017
5	Antidepressive Agents (Antidepressants)IBA 01/2017 - 10/2005
4	Therapeutic UsesIBA 01/2022 - 03/2003
4	PlasticsIBA 04/2017 - 04/2006
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016 - 06/2006
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 05/2021 - 12/2010
2	Cholinergic Agents (Cholinergics)IBA 01/2022 - 05/2021
2	C-Reactive ProteinIBA 01/2022 - 11/2017
2	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2022
2	Testosterone (Sustanon)FDA Link 01/2020 - 12/2019
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 01/2013
2	Memantine (Namenda)FDA Link 01/2020 - 01/2020
2	erucylphosphocholineIBA 08/2019 - 01/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016 - 07/2014
2	Kainic Acid (Kainate)IBA 01/2016 - 12/2008
2	Lorazepam (Ativan)FDA LinkGeneric 01/2016 - 08/2015
2	Antipsychotic Agents (Antipsychotics)IBA 09/2014 - 07/2002
2	ElementsIBA 04/2008 - 04/2006
1	ApolipoproteinsIBA 01/2022
1	NeuropeptidesIBA 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2022
1	progressinIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2021
1	ezogabine (retigabine)IBA 01/2021
1	UbiquitinIBA 11/2020
1	Glial Fibrillary Acidic ProteinIBA 11/2020
1	HydrolasesIBA 11/2020
1	tetraethylpyrazine (TEP)IBA 01/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2020

Therapy/Procedure

103	Transcranial Magnetic Stimulation 01/2022 - 07/2002
47	Transcranial Direct Current Stimulation 01/2022 - 09/2005
18	Therapeutics 01/2021 - 12/2005
6	Electrodes (Electrode) 01/2019 - 01/2004
4	Cognitive Training 01/2020 - 10/2008
2	Drug Therapy (Chemotherapy) 05/2016 - 01/2016
2	Neurological Rehabilitation 01/2015 - 01/2014
2	Deep Brain Stimulation 10/2014 - 01/2014
2	OPEN protocol 01/2014 - 04/2005
2	Aftercare (After-Treatment) 09/2010 - 03/2010